Federici Augusto Bramante
Adjunct Professor
Contacts
Additional phone numbers
University email address
Teaching - Programme courses
Bachelors and masters
A.Y. 2025/2026
A.Y. 2024/2025
A.Y. 2023/2024
A.Y. 2022/2023
A.Y. 2021/2022
A.Y. 2020/2021
Postgraduate programmes
A.Y. 2024/2025
Advanced course
- Attività didattica del corso di perfezionamento (Farmacia in Oncologia (7ZT))
2nd level vocational master
- Oncological Pathology and Other Therapies (Master in farmacia e farmacologia oncologica - ii livello)
A.Y. 2023/2024
2nd level vocational master
- Oncological Pathology and Other Therapies (Master in farmacia e farmacologia oncologica - ii livello)
A.Y. 2022/2023
2nd level vocational master
- Oncological Pathology and Other Therapies (Master in farmacia e farmacologia oncologica - ii livello)
Research
Publications
-
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS / M.T. Pagliari, U. Budde, L. Baronciani, P. Eshghi, M. Ahmadinejad, Z. Badiee, M. Baghaipour, O. Benítez Hidalgo, E. Biguzzi, I. Bodó, G. Castaman, J. Goudemand, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F. Lopez Fernandez, R. Marino, J. Oldenburg, I. Peake, C. Santoro, R. Schneppenheim, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, H. Yadegari, E.M.K. Zetterberg, P.M. Mannucci, A.B. Federici, J. Eikenboom, F. Peyvandi. - In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. - ISSN 1538-7836. - 21:4(2023 Apr), pp. 787-799. [10.1016/j.jtha.2023.01.001]
-
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort / M. Merli, I. Ferrarini, F. Merli, A. Busca, R. Mina, B. Falini, R. Bruna, R. Cairoli, M. Marchetti, A. Romano, M. Cavo, L. Arcaini, L. Trentin, C. Cattaneo, E. Derenzini, N.S. Fracchiolla, F. Marchesi, A. Scattolin, A. Billio, M. Bocchia, M. Massaia, C. Gambacorti-Passerini, F.R. Mauro, M. Gentile, S. Mohamed, M.G. Della Porta, E. Coviello, D. Cilloni, G. Visani, A.B. Federici, M.C. Tisi, L. Cudillo, S. Galimberti, F. Gherlinzoni, L. Pagano, A. Guidetti, L. Bertù, P. Corradini, F. Passamonti, C. Visco. - In: HEMATOLOGICAL ONCOLOGY. - ISSN 1099-1069. - 41:1(2023), pp. 128-138. [10.1002/hon.3092]
-
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study / M.T. Pagliari, F.R. Rosendaal, M. Ahmadinejad, Z. Badiee, M. Baghaipour, L. Baronciani, O. Benítez Hidalgo, I. Bodó, U. Budde, G. Castaman, P. Eshghi, J. Goudemand, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F. Lopez Fernandez, P.M. Mannucci, R. Marino, J. Oldenburg, I. Peake, C. Santoro, R. Schneppenheim, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, H. Yadegari, E.M.K. Zetterberg, F. Peyvandi, A.B. Federici, J. Eikenboom. - In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. - ISSN 1538-7836. - 20:5(2022 May), pp. 1106-1114. [10.1111/jth.15658]
-
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS / L. Baronciani, I. Peake, R. Schneppenheim, A. Goodeve, M. Ahmadinejad, Z. Badiee, M.-. Baghaipour, O. Benitez, I. Bodo, U. Budde, A. Cairo, G. Castaman, P. Eshghi, J. Goudemand, W. Hassenpflug, H. Hoorfar, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F.L. Fernandez, P.M. Mannucci, R. Marino, N. Niksic, F. Oyen, C. Santoro, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, E.M.K. Zetterberg, J. Eikenboom, A.B. Federici, F. Peyvandi. - In: BLOOD ADVANCES. - ISSN 2473-9529. - 5:15(2021 Aug 10), pp. 2987-3001. [10.1182/bloodadvances.2020003397]
-
Unexpected Neurological Symptoms of Ruxolitinib: A Case Report / F. Furia, M.P. Canevini, A.B. Federici, M.C. Carraro. - In: JOURNAL OF HEMATOLOGY. - ISSN 1927-1212. - 9:4(2020 Dec), pp. 137-139. [10.14740/jh642]